Literature DB >> 7789645

Bone loss and bone turnover in diabetes.

J C Krakauer1, M J McKenna, N F Buderer, D S Rao, F W Whitehouse, A M Parfitt.   

Abstract

There have been conflicting reports about the effect of diabetes on bone density. In 1978, we studied 109 patients, 46 with type I and 63 with type II diabetes; approximately 12 years later we restudied 35 of the 66 surviving patients. In the original study, radial bone density did not differ significantly between patients with either type of diabetes but was significantly lower than in nondiabetic control subjects. In eight osteopenic patients, bone formation rate and other histological indexes of osteoblast recruitment and function were markedly depressed compared with those in nondiabetic control subjects. In patients remeasured approximately 2.5 years (41 patients) and approximately 12.5 years (35 patients) after baseline, bone loss had continued at the expected rate in patients with type I diabetes, with maintenance of the same deficit, but was slower than expected in patients with type II diabetes, such that the initial deficit had been completely corrected. In six of the eight patients who had undergone bone biopsy, one with type I and five with type II diabetes, the mean bone mineral density z-score of the spine and femoral neck approximately 12 years later was > 0 and in one subject was significantly higher than normal at both sites. Based on these data and on previous studies, we propose that in patients with diabetes, low bone formation retards bone accumulation during growth, metabolic effects of poor glycemic control lead to increased bone resorption and bone loss in young adults, and low bone turnover retards age-related bone loss.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7789645     DOI: 10.2337/diab.44.7.775

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  118 in total

1.  Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK).

Authors:  Ana M Cortizo; María G Lettieri; Daniel A Barrio; Natalia Mercer; Susana B Etcheverry; Antonio D McCarthy
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

2.  Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies.

Authors:  Lili Ma; Ling Oei; Lindi Jiang; Karol Estrada; Huiyong Chen; Zhen Wang; Qiang Yu; Maria Carola Zillikens; Xin Gao; Fernando Rivadeneira
Journal:  Eur J Epidemiol       Date:  2012-03-27       Impact factor: 8.082

3.  Bone histomorphometry in diabetes mellitus.

Authors:  C A Moreira; D W Dempster
Journal:  Osteoporos Int       Date:  2015-08-05       Impact factor: 4.507

4.  Trabecular bone histomorphometry in humans with Type 1 Diabetes Mellitus.

Authors:  Laura A G Armas; Mohammed P Akhter; Andjela Drincic; Robert R Recker
Journal:  Bone       Date:  2011-10-07       Impact factor: 4.398

5.  RIP140 in monocytes/macrophages regulates osteoclast differentiation and bone homeostasis.

Authors:  Bomi Lee; Urszula T Iwaniec; Russell T Turner; Yi-Wei Lin; Bart L Clarke; Anne Gingery; Li-Na Wei
Journal:  JCI Insight       Date:  2017-04-06

Review 6.  Marrow fat metabolism is linked to the systemic energy metabolism.

Authors:  Beata Lecka-Czernik
Journal:  Bone       Date:  2011-07-04       Impact factor: 4.398

7.  The preventive effects of pulsed electromagnetic fields on diabetic bone loss in streptozotocin-treated rats.

Authors:  D Jing; J Cai; G Shen; J Huang; F Li; J Li; L Lu; E Luo; Q Xu
Journal:  Osteoporos Int       Date:  2010-10-26       Impact factor: 4.507

8.  Bone metabolism in male patients with type 2 diabetes.

Authors:  Lahsen Achemlal; Saida Tellal; Fouad Rkiouak; Abderrazak Nouijai; Ahmed Bezza; El Mostapha Derouiche; Driss Ghafir; Abdellah El Maghraoui
Journal:  Clin Rheumatol       Date:  2005-03-04       Impact factor: 2.980

9.  Bone metabolism and the 10-year probability of hip fracture and a major osteoporotic fracture using the country-specific FRAX algorithm in men over 50 years of age with type 2 diabetes mellitus: a case-control study.

Authors:  Harjit P Bhattoa; Ugo Onyeka; Edit Kalina; Adam Balogh; Gyorgy Paragh; Peter Antal-Szalmas; Miklos Kaplar
Journal:  Clin Rheumatol       Date:  2013-04-16       Impact factor: 2.980

10.  Osteogenic protein-1 overcomes inhibition of fracture healing in the diabetic rat: a pilot study.

Authors:  Louis S Kidder; Xinqian Chen; Andrew H Schmidt; William D Lew
Journal:  Clin Orthop Relat Res       Date:  2008-07-29       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.